search results for: astrazeneca

J&J's Janssen nabs new in­di­ca­tion, full ap­proval for can­cer drug Ry­bre­vant

Last month
R&D
FDA+

Judge rules against As­traZeneca in suit over IRA price ne­go­ti­a­tions

Last month
Pharma
Law

Pfiz­er names a VC leader in year of re­set; For­mer Ax­cel­la CEO moves on af­ter com­pa­ny shut­down

Last month
People
Peer Review

As­traZeneca bails on rox­adu­s­tat’s fu­ture in the US, but keeps Chi­na pact with Fi­bro­Gen

Last month
Deals

Ab­b­Vie’s next CEO; $100B club re­fresh; Top 100 VCs, 2023; More hope for CAR-T in au­toim­mune; and more

Last month
Weekly

Am­gen wants in on obe­si­ty. But it's still work­ing on rare dis­ease, too

Last month
R&D
Pharma

Karuna push­es back KarXT da­ta read­outs; Vir, GSK end flu col­lab­o­ra­tion; Si­lence’s $10M mile­stone pay­ment

Last month
News Briefing

There­sa Heah en­ters the bat cave at Para­tus; Eli Lil­ly ex­ec takes CFO job at Jazz Phar­ma­ceu­ti­cals

Last month
Peer Review

FDA grants pri­or­i­ty re­view for Dupix­ent in COPD, sets June ap­proval de­ci­sion dead­line

Last month
R&D
FDA+

Fron­tier Med­i­cines rais­es $80M, en­ters clin­ic and eyes po­ten­tial IPO in Q4 or ear­ly 2025

Last month
Financing
Startups

Al­ny­lam CEO de­fends changes to cru­cial AT­TR tri­al: 'We re­al­ly are play­ing to win'

Last month
R&D

Up­dat­ed: NJ court says drug­mak­ers can co­or­di­nate their le­gal fight against the gov­ern­men­t's price ne­go­ti­a­tions

Last month
Pharma
Law

Rick Gon­za­lez de­fend­ed Ab­b­Vie's em­pire. The next CEO will have to build a new one be­yond Hu­mi­ra

Last month
People
Pharma

Mar­ket­ingRx roundup: Op­di­vo, Veozah on Peo­ple’s Choice Awards; AZ pub­lish­es new sus­tain­abil­i­ty re­port

Last month
Pharma
Marketing

Io­vance's $211M of­fer­ing; Almi­rall li­cens­es No­vo drug; As­traZeneca files Da­to-DXd; Sonata lay­offs

Last month
News Briefing

Com­peti­tor man­u­fac­tur­ers could ben­e­fit from No­vo’s ac­qui­si­tion of Catal­ent, Siegfried CEO says

Last month
Manufacturing

Dai­ichi Sankyo in­vests $1B to bulk out Ger­man site for can­cer AD­Cs 

Last month
Manufacturing

As­traZeneca’s Tagris­so hits the mark in late-stage lung can­cer main­te­nance study

Last month
R&D
First page Previous page 2345678 Next page Last page

latest

Most read

A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

15 hours ago
AI
Pharma

Ex­clu­sive: An­ces­try cut 6% of work­force as ge­neal­o­gy gi­ant strug­gles with sub­scrip­tion rev­enue

12 hours ago
People
Health Tech

GSK un­veils long-term Shin­grix da­ta as shin­gles com­pe­ti­tion heats up

14 hours ago
R&D
Pharma

Lil­ly, in­sulin users end $13.5M set­tle­ment plan fol­low­ing fed­er­al judge's de­ci­sion

14 hours ago
Pharma
Law
see latest stream
A service from the Financial Times